Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Blood Specimen Collection × Plasma cell × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 16 Breast 15 Genitourinary 8 Thoracic 7 Sarcoma 7 Gynecologic 7 CNS 7 Other hematologic neoplasm 6 Myeloid 6 Lymphoid 6 Tumor-Agnostic 4 Dermatologic 4 Head & Neck 3 Other solid neoplasm 2 Plasma cell 1 Other neoplasm 1 Endocrine 1

Conditions

Multiple Myeloma 1

Interventions

Dexamethasone 114 Lenalidomide 74 daratumumab 63 Bortezomib 52 pomalidomide 40 Calcium Dobesilate 38 carfilzomib 37 Cyclophosphamide 33 Specimen Handling 26 Biopsy 23 talquetamab 19 isatuximab 19 fludarabine 19 Magnetic Resonance Spectroscopy 19 dexamethasone acetate 16 dexamethasone 21-phosphate 16 belantamab mafodotin 16 auricularum 16 iberdomide 15 selinexor 14 elotuzumab 10 tocilizumab 8 fludarabine phosphate 8 X-Rays 8 venetoclax 7 ixazomib 7 trametinib 6 Whole-Body Irradiation 6 Phantoms, Imaging 6 Melphalan 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07342179 2026-02-18

CART I5M

Poitiers University Hospital

Phase NA Recruiting

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡